| Literature DB >> 28003822 |
Bannakij Lojanapiwat1, Pattara Rod-Ong1, Pruit Kitirattrakarn1, Wilaiwan Chongruksut1.
Abstract
Objective. To predict the success rate and complications following percutaneous nephrolithotomy via the upper pole using the Guy's Stone Score (GSS) based on the findings of a preoperative intravenous pyelogram (IVP). Patients and Methods. Two hundred and twenty-seven renal operations, which were carried out using PCNL via the upper pole, were classified according to the GSS assigned. Any complications were classified according to the Clavien classification. The success rates and incidence of any complications were compared between each GSS. Results. The immediate success rates were 87.50% of GSS1, 71.43% of GSS2, 53.62% of GSS3, and 38.46% of GSS4, P < 0.01. There were statistically significant differences between the groups in stone size, overall immediate success rate, operative time, number of access tracts, and frequency of tubeless PCNL. Major complications (a Clavien score of 3-5) were significantly higher in the cases with a higher GSS. Conclusion. A GSS based on an IVP is a simple and reliable tool in predicting the success rate and possible complications following upper pole access PCNL.Entities:
Year: 2016 PMID: 28003822 PMCID: PMC5143681 DOI: 10.1155/2016/5157930
Source DB: PubMed Journal: Adv Urol ISSN: 1687-6369
The demographic data of total upper pole access patients (N = 227).
| GSS1 | GSS2 | GSS3 | GSS4 |
| |
|---|---|---|---|---|---|
|
|
|
|
| ||
| Age (year) | |||||
| Mean (SD) | 54.28 (13.34) | 51.77 (10.07) | 55.52 (0.961) | 55.51 (10.03) | 0.13 |
| Gender, | |||||
| Male : female | 12 : 20 | 21 : 14 | 48 : 21 | 62 : 29 | 0.01 |
| Previous surgery, | 10 (31.25) | 10 (28.57) | 16 (23.19) | 22 (24.18) | 0.79 |
| Stone side, ( | |||||
| Right : left | 17 : 15 | 15 : 20 | 37 : 32 | 50 : 41 | 0.67 |
| Size (mm): | |||||
| Mean (SD) | 27.03 (0.60) | 26.42 (10.09) | 42.28 (11.79) | 63.24 (17.28) | <0.01 |
| BMI, | |||||
| 18–25 cm/kg2 | 33 (66.34) | 19 (63.33) | 42 (73.22) | 35 (76.08) | 0.75 |
| >25 cm/kg2 | 16 (32.65) | 11 (36.67) | 15 (26.79) | 11 (23.91) | |
| Comorbidities | |||||
| Diabetes, | 4 (13.79) | 7 (21.88) | 10 (20.83) | 11 (16.92) | 0.81 |
| Hypertension, | 12 (41.38) | 11 (34.38) | 22 (45.83) | 33 (50.77) | 0.47 |
| Dyslipidemia, | 7 (24.14) | 6 (18.75) | 8 (16.67) | 15 (23.08) | 0.81 |
| Blood Cr., | |||||
| <1.5 mg% | 43 (78.18) | 23 (74.19) | 53 (88.33) | 40 (74.07) | 0.22 |
| >1.5 mg% | 12 (21.82) | 8 (25.81) | 7 (11.67) | 14 (25.93) | |
Outcomes of total upper pole access operations (N = 227).
| GSS1 | GSS2 | GSS3 | GSS4 |
| |
|---|---|---|---|---|---|
|
|
|
|
| ||
| Number of access tracts, | |||||
| Mean (SD) | |||||
| 1 | 31 (96.88) | 33 (94.29) | 61 (88.41) | 82 (90.11) | 0.48 |
| >1 | 1 (3.13) | 2 (5.71) | 8 (11.54) | 9 (9.89) | |
| Op. time (min) | |||||
| mean (SD) | 48.21 (21.70) | 65.5 (23.80) | 68.91 (24.43) | 76.30 (33.44) | <0.01 |
| Blood transfusion | |||||
| mean (SD) | 1 (3.13) | 3 (8.57) | 4 (5.80) | 4 (4.40) | 0.76 |
| Tubeless, | 6 (18.75) | 7 (20.00) | 6 (8.70) | 5 (5.49) | 0.03 |
| Immediate success | |||||
|
| 28 (87.50) | 25 (71.43) | 37 (53.62) | 35 (38.46) | <0.01 |
| Complications, | |||||
| Minor (Clavien 1-2) | 3 (9.37) | 14 (40.00) | 21 (30.43) | 25 (20.47) | <0.01 |
| Major (Clavien 3–5) | 0 | 2 (5.70) | 7 (10.14) | 13 (16.48) | <0.01 |
| Sepsis | 0 | 1 | 5 | 5 | |
| Pulmonary complication | 0 | 1 | 1 | 5 | |
| Other | 0 | 0 | 1 | 3 | |
| Auxiliary treatment and | |||||
| re-PCNL, | 2 (6.25) | 1 (2.86) | 18 (25.99) | 38 (41.75) | 0.02 |
The demographic data of supracostal upper access patients (N = 81).
| GSS1 | GSS2 | GSS3 | GSS4 |
| |
|---|---|---|---|---|---|
|
|
|
|
| ||
| Age (year), | |||||
| Mean (SD) | 51 (18.14) | 53 (10.68) | 51.52 (9.17) | 53.24 (9.29) | 0.11 |
| Gender, ( | |||||
| Male : female | 1 : 5 | 8 : 1 | 16 : 9 | 32 : 9 | 0.01 |
| Previous surgery, | 1 (16.67) | 1 (11.11) | 5 (20.00) | 11 (26.83) | 0.81 |
| Stone side, | |||||
| Right : left | 31 : 25 | 14 : 18 | 29 : 34 | 27 : 29 | 0.72 |
| Size (mm), | |||||
| Mean (SD) | 24.16 (3.43) | 7 (9.15) | 43.27 (11.91) | 61.97 (20.04) | <0.01 |
| BMI | |||||
| 18–25 cm/kg2 | 3 (50.00) | 6 (75.00) | 13 (68.42) | 23 (65.76) | 0.91 |
| >25 cm/kg2 | 3 (50.00) | 2 (25.00) | 6 (31.58) | 10 (31.25) | |
| Comorbidities | |||||
| Diabetes, | 1 (16.67) | 2 (25.00) | 5 (33.33) | 6 (20.00) | 0.76 |
| Hypertension, | 3 (50.00) | 2 (25.00) | 6 (40.00) | 15 (50.00) | 0.62 |
| Dyslipidemia, | 2 (33.30) | 1 (12.50) | 2 (13.33) | 7 (23.33) | 0.67 |
| Blood Cr. | |||||
| <1.5 mg% | 5 (83.33) | 5 (62.50) | 17 (77.27) | 26 (65.00) | 0.63 |
| >1.5 mg% | 1 (16.67) | 3 (37.50) | 5 (22.73) | 14 (35.00) | |
Outcomes of supracostal upper pole access operations (N = 81).
| GSS1 | GSS2 | GSS3 | GSS4 |
| |
|---|---|---|---|---|---|
|
|
|
|
| ||
| Operative time (min) | |||||
| Mean (SD) | 50.57 (20.31) | 67 (24.50) | 68.46 (23.00) | 78.71 (35.09) | 0.17 |
| Number of access tracts | |||||
| 1 | 6 (100.00) | 8 (88.89) | 23 (92.00) | 39 (95.12) | 0.68 |
| >1 | 0 (0.00) | 1 (11.11) | 2 (8.00) | 2 (4.88) | |
| Immediate success rate | 5 (83.33) | 6 (66.66) | 16 (64.0) | 14 (34.14) | <0.01 |
| Blood transfusion | 1 (16.67) | 1 (11.11) | 2 (8.00) | 2 (4.88) | 0.41 |
| Complications, | |||||
| Minor (Clavien 1-2) | 0 (0) | 4 (33.33) | 8 (32.00) | 5 (12.19) | |
| Major (Clavien 3–5) | 0 (0) | 1 (11.11) | 5 (20.00) | 12 (29.20) | 0.03 |
| Sepsis | 0 | 0 | 2 | 4 | |
| Pulmonary complication | 0 | 1 | 1 | 6 | |
| Other | 0 | 0 | 2 | 2 | |
| Auxiliary treatment and re-PCNL, | 1 (16.67) | 0 (0) | 8 (32.00) | 15 (36.58) | 0.21 |